Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Abeona Therapeutics Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 53 | 56 | +3 |
| Shares | 40.9M | 32.6M | −8.28M (−20.2%) |
| Value | $13.7M | $10.3M | −$3.39M (−24.8%) |
New holders (11)
Institutions that held Abeona Therapeutics Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 99,062 | $31.0K | 0.00% |
| Citigroup Inc | 86,935 | $27.0K | 0.00% |
| Stratos Wealth Partners, LTD. | 40,000 | $13.0K | 0.00% |
| M Holdings Securities, Inc. | 36,800 | $12.0K | 0.00% |
| Two Sigma Securities, LLC | 27,103 | $9.00K | 0.00% |
| Jane Street Group, LLC | 29,691 | $9.00K | 0.00% |
| Hartford Financial Management Inc. | 18,680 | $6.00K | 0.00% |
| Parallel Advisors, LLC | 10,000 | $3.00K | 0.00% |
| Money Concepts Capital Corp | 5,000 | $2.00K | 0.00% |
| Global Retirement Partners, LLC | 6 | $0 | 0.00% |
| IFP Advisors, Inc | 10,000 | – | – |
Sold out (8)
Institutions that held Abeona Therapeutics Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 788,085 | $266.0K |
| Virtu Financial LLC | 250,637 | $84.0K |
| Acadian Asset Management LLC | 236,681 | $78.0K |
| Charles Schwab Investment Management Inc | 35,285 | $12.0K |
| Susquehanna International Group, LLP | 11,176 | $4.00K |
| Royal Bank of Canada | 6,775 | $2.00K |
| Truvestments Capital LLC | 1,380 | $0 |
| Banque Cantonale Vaudoise | 1 | $0 |